In addition, (R)2-hydroxyglutarate (R-2HG), a cancer metabolite associated with mutant isocitrate dehydrogenases(IDH) in leukemias and gliomas, exerts anti-tumor effects by suppressing FTO and increasing total levels of m6A [24]. This evidence concerns the gene IDH1 and leukemia.